Galectin-3 is a sensor-regulator of toll-like receptor pathways in synovial fibroblasts

Cytokine

Volumn 73, Issue 1, 2015, Pages 30-35

  Arad, Uri ^a   Madar Balakirski, Noa ^a   Angel Korman, Avital ^a   Amir, Sharon ^a   Tzadok, Sharon ^a   Segal, Ortal ^a   Menachem, Aharon ^a   Gold, Aviram ^a   Elkayam, Ori ^a   Caspi, Dan ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Galectin 3; Rheumatoid Arthritis; Synovial fibroblasts; Synovitis; Toll like receptors

Indexed keywords

GALECTIN 3; INTERLEUKIN 6; PECTIN; PHORBOL 13 ACETATE 12 MYRISTATE; RANTES; SMALL INTERFERING RNA; STROMELYSIN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; LIPOPEPTIDE; LIPOPOLYSACCHARIDE; MMP3 PROTEIN, HUMAN; PAM(3)CSK(4) PEPTIDE;

ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CYTOKINE RELEASE; FIBROBLAST; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS REGULATION; SYNOVIUM; CYTOLOGY; DRUG EFFECTS; METABOLISM; SECRETION (PROCESS); SIGNAL TRANSDUCTION;

CITRUS;

CHEMOKINE CCL5; FIBROBLASTS; GALECTIN 3; GENE KNOCKDOWN TECHNIQUES; HUMANS; INTERLEUKIN-6; LIPOPEPTIDES; LIPOPOLYSACCHARIDES; MATRIX METALLOPROTEINASE 3; SIGNAL TRANSDUCTION; SYNOVIAL MEMBRANE; TETRADECANOYLPHORBOL ACETATE; TOLL-LIKE RECEPTORS;

EID: 84922712290     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.01.016     Document Type: Article

References (46)

1. McInnes I.B., Schett G. The pathogenesis of rheumatoid arthritis. N Engl J Med 2011, 365:2205-2219.
2. Neumann E., Lefevre S., Zimmermann B., Gay S., Muller-Ladner U. Rheumatoid arthritis progression mediated by activated synovial fibroblasts. Trends Mol Med 2010, 16:458-468.
3. Alsaleh G., Sparsa L., Chatelus E., Ehlinger M., Gottenberg J.E., Wachsmann D., et al. Innate immunity triggers IL-32 expression by fibroblast-like synoviocytes in rheumatoid arthritis. Arthritis Res Ther 2010, 12:R135.
4. Kim K.W., Cho M.L., Lee S.H., Oh H.J., Kang C.M., Ju J.H., et al. Human rheumatoid synovial fibroblasts promote osteoclastogenic activity by activating RANKL via TLR-2 and TLR-4 activation. Immunol Lett 2007, 110:54-64.
5. Dumic J., Dabelic S., Flogel M. Galectin-3: an open-ended story. Biochim Biophys Acta 2006, 1760:616-635.
6. Henderson N.C., Sethi T. The regulation of inflammation by galectin-3. Immunol Rev 2009, 230:160-171.
7. Liu F.T., Yang R.Y., Hsu D.K. Galectins in acute and chronic inflammation. Ann NY Acad Sci 2012, 1253:80-91.
8. Rabinovich G.A., Toscano M.A. Turning 'sweet' on immunity: galectin-glycan interactions in immune tolerance and inflammation. Nat Rev Immunol 2009, 9:338-352.
9. Vasta G.R. Roles of galectins in infection. Nat Rev Microbiol 2009, 7:424-438.
10. Lepur A., Salomonsson E., Nilsson U.J., Leffler H. Ligand induced galectin-3 protein self-association. J Biol Chem 2012, 287:21751-21756.
11. Nieminen J., Kuno A., Hirabayashi J., Sato S. Visualization of galectin-3 oligomerization on the surface of neutrophils and endothelial cells using fluorescence resonance energy transfer. J Biol Chem 2007, 282:1374-1383.
12. Chen I.J., Chen H.L., Demetriou M. Lateral compartmentalization of T cell receptor versus CD45 by galectin-N-glycan binding and microfilaments coordinate basal and activation signaling. J Biol Chem 2007, 282:35361-35372.
13. Partridge E.A., Le Roy C., Di Guglielmo G.M., Pawling J., Cheung P., Granovsky M., et al. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 2004, 306:120-124.
14. Ohshima S., Kuchen S., Seemayer C.A., Kyburz D., Hirt A., Klinzing S., et al. Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum 2003, 48:2788-2795.
15. Dasuri K., Antonovici M., Chen K., Wong K., Standing K., Ens W., et al. The synovial proteome: analysis of fibroblast-like synoviocytes. Arthritis Res Ther 2004, 6:R161-R168.
16. Neidhart M., Zaucke F., von Knoch R., Jungel A., Michel B.A., Gay R.E., et al. Galectin-3 is induced in rheumatoid arthritis synovial fibroblasts after adhesion to cartilage oligomeric matrix protein. Ann Rheum Dis 2005, 64:419-424.
17. Filer A., Bik M., Parsonage G.N., Fitton J., Trebilcock E., Howlett K., et al. Galectin 3 induces a distinctive pattern of cytokine and chemokine production in rheumatoid synovial fibroblasts via selective signaling pathways. Arthritis Rheum 2009, 60:1604-1614.
18. Forsman H., Islander U., Andreasson E., Andersson A., Onnheim K., Karlstrom A., et al. Galectin 3 aggravates joint inflammation and destruction in antigen-induced arthritis. Arthritis Rheum 2011, 63:445-454.
19. Wang C.R., Shiau A.L., Chen S.Y., Cheng Z.S., Li Y.T., Lee C.H., et al. Intra-articular lentivirus-mediated delivery of galectin-3 shRNA and galectin-1 gene ameliorates collagen-induced arthritis. Gene Ther 2010, 17:1225-1233.
20. Hirschfeld M., Ma Y., Weis J.H., Vogel S.N., Weis J.J. Cutting edge: repurification of lipopolysaccharide eliminates signaling through both human and murine toll-like receptor 2. J Immunol 2000, 165:618-622.
21. Rosengren S., Boyle D.L., Firestein G.S. Acquisition, culture, and phenotyping of synovial fibroblasts. Meth Mol Med 2007, 135:365-375.
22. Neidhart M., Seemayer C.A., Hummel K.M., Michel B.A., Gay R.E., Gay S. Functional characterization of adherent synovial fluid cells in rheumatoid arthritis: destructive potential in vitro and in vivo. Arthritis Rheum 2003, 48:1873-1880.
23. Platt D., Raz A. Modulation of the lung colonization of B16-F1 melanoma cells by citrus pectin. J Natl Cancer Inst 1992, 84:438-442.
24. Mey A., Leffler H., Hmama Z., Normier G., Revillard J.P. The animal lectin galectin-3 interacts with bacterial lipopolysaccharides via two independent sites. J Immunol 1996, 156:1572-1577.
25. Lin H.M., Pestell R.G., Raz A., Kim H.R. Galectin-3 enhances cyclin D(1) promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells. Oncogene 2002, 21:8001-8010.
26. Vyakarnam A., Dagher S.F., Wang J.L., Patterson R.J. Evidence for a role for galectin-1 in pre-mRNA splicing. Mol Cell Biol 1997, 17:4730-4737.
27. Clark M.C., Pang M., Hsu D.K., Liu F.T., de Vos S., Gascoyne R.D., et al. Galectin-3 binds to CD45 on diffuse large B-cell lymphoma cells to regulate susceptibility to cell death. Blood 2012, 120:4635-4644.
28. Pienta K.J., Naik H., Akhtar A., Yamazaki K., Replogle T.S., Lehr J., et al. Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst 1995, 87:348-353.
29. Li Y., Komai-Koma M., Gilchrist D.S., Hsu D.K., Liu F.T., Springall T., et al. Galectin-3 is a negative regulator of lipopolysaccharide-mediated inflammation. J Immunol 2008, 181:2781-2789.
30. Bernardes E.S., Silva N.M., Ruas L.P., Mineo J.R., Loyola A.M., Hsu D.K., et al. Toxoplasma gondii infection reveals a novel regulatory role for galectin-3 in the interface of innate and adaptive immunity. Am J Pathol 2006, 168:1910-1920.
31. MacKinnon A.C., Farnworth S.L., Hodkinson P.S., Henderson N.C., Atkinson K.M., Leffler H., et al. Regulation of alternative macrophage activation by galectin-3. J Immunol 2008, 180:2650-2658.
32. Demetriou M., Granovsky M., Quaggin S., Dennis J.W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 2001, 409:733-739.
33. Goetz J.G., Joshi B., Lajoie P., Strugnell S.S., Scudamore T., Kojic L.D., et al. Concerted regulation of focal adhesion dynamics by galectin-3 and tyrosine-phosphorylated caveolin-1. J Cell Biol 2008, 180:1261-1275.
34. Markowska A.I., Jefferies K.C., Panjwani N. Galectin-3 protein modulates cell surface expression and activation of vascular endothelial growth factor receptor 2 in human endothelial cells. J Biol Chem 2011, 286:29913-29921.
35. Amith S.R., Jayanth P., Franchuk S., Siddiqui S., Seyrantepe V., Gee K., et al. Dependence of pathogen molecule-induced toll-like receptor activation and cell function on Neu1 sialidase. Glycoconj J 2009, 26:1197-1212.
36. Amith S.R., Jayanth P., Franchuk S., Finlay T., Seyrantepe V., Beyaert R., et al. Neu1 desialylation of sialyl alpha-2,3-linked beta-galactosyl residues of TOLL-like receptor 4 is essential for receptor activation and cellular signaling. Cell Signal 2010, 22:314-324.
37. Stamatos N.M., Carubelli I., van de Vlekkert D., Bonten E.J., Papini N., Feng C., et al. LPS-induced cytokine production in human dendritic cells is regulated by sialidase activity. J Leukoc Biol 2010, 88:1227-1239.
38. Abdollahi-Roodsaz S., van de Loo F.A., van den Berg W.B. Trapped in a vicious loop: toll-like receptors sustain the spontaneous cytokine production by rheumatoid synovium. Arthritis Res Ther 2011, 13:105.
39. Goh F.G., Midwood K.S. Intrinsic danger: activation of Toll-like receptors in rheumatoid arthritis. Rheumatology (Oxford) 2012, 51:7-23.
40. Drexler S.K., Kong P., Inglis J., Williams R.O., Garlanda C., Mantovani A., et al. SIGIRR/TIR-8 is an inhibitor of toll-like receptor signaling in primary human cells and regulates inflammation in models of rheumatoid arthritis. Arthritis Rheum 2010, 62:2249-2261.
41. Sacre S.M., Andreakos E., Kiriakidis S., Amjadi P., Lundberg A., Giddins G., et al. The toll-like receptor adaptor proteins MyD88 and Mal/TIRAP contribute to the inflammatory and destructive processes in a human model of rheumatoid arthritis. Am J Pathol 2007, 170:518-525.
42. Ultaigh S.N., Saber T.P., McCormick J., Connolly M., Dellacasagrande J., Keogh B., et al. Blockade of toll-like receptor 2 prevents spontaneous cytokine release from rheumatoid arthritis ex vivo synovial explant cultures. Arthritis Res Ther 2011, 13:R33.
43. Abdollahi-Roodsaz S., Joosten L.A., Roelofs M.F., Radstake T.R., Matera G., Popa C., et al. Inhibition of toll-like receptor 4 breaks the inflammatory loop in autoimmune destructive arthritis. Arthritis Rheum 2007, 56:2957-2967.
44. Dong L., Ito S., Ishii K.J., Klinman D.M. Suppressive oligonucleotides protect against collagen-induced arthritis in mice. Arthritis Rheum 2004, 50:1686-1689.
45. Zeuner R.A., Ishii K.J., Lizak M.J., Gursel I., Yamada H., Klinman D.M., et al. Reduction of CpG-induced arthritis by suppressive oligodeoxynucleotides. Arthritis Rheum 2002, 46:2219-2224.
46. Oberg C.T., Leffler H., Nilsson U.J. Inhibition of galectins with small molecules. Chimia (Aarau) 2011, 65:18-23.